Michael J. Goodman

7.6k total citations
101 papers, 5.6k citations indexed

About

Michael J. Goodman is a scholar working on Epidemiology, Economics and Econometrics and Genetics. According to data from OpenAlex, Michael J. Goodman has authored 101 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 15 papers in Economics and Econometrics and 14 papers in Genetics. Recurrent topics in Michael J. Goodman's work include Traffic and Road Safety (12 papers), Inflammatory Bowel Disease (11 papers) and Healthcare Policy and Management (11 papers). Michael J. Goodman is often cited by papers focused on Traffic and Road Safety (12 papers), Inflammatory Bowel Disease (11 papers) and Healthcare Policy and Management (11 papers). Michael J. Goodman collaborates with scholars based in United States, United Kingdom and Canada. Michael J. Goodman's co-authors include Mark C. Hornbrook, S A Riley, V Mani, Michael V. Maciosek, Leif I. Solberg, Nichol M. Edwards, Ashley B. Coffield, Shoma Dutt, M E Herd and Richard Platt and has published in prestigious journals such as The Lancet, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Michael J. Goodman

97 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Goodman United States 36 1.6k 991 968 878 776 101 5.6k
Risto P. Roine Finland 42 940 0.6× 281 0.3× 1.6k 1.7× 776 0.9× 894 1.2× 236 6.4k
Deborah Symmons United Kingdom 87 2.4k 1.6× 1.2k 1.2× 2.7k 2.8× 1.0k 1.2× 564 0.7× 396 27.2k
Ferrán Catalá-López Spain 28 1.0k 0.7× 312 0.3× 1.5k 1.6× 515 0.6× 638 0.8× 127 8.9k
Tom Marshall United Kingdom 42 1.1k 0.7× 357 0.4× 862 0.9× 1.1k 1.3× 1.1k 1.4× 250 7.3k
John G Williams United Kingdom 37 993 0.6× 887 0.9× 1.3k 1.4× 256 0.3× 406 0.5× 143 4.2k
Jeroen P. Jansen United States 40 1.4k 0.9× 417 0.4× 2.1k 2.2× 930 1.1× 461 0.6× 146 12.1k
Emmanuel Lesaffre Belgium 51 2.5k 1.6× 272 0.3× 1.6k 1.7× 505 0.6× 803 1.0× 236 10.5k
Julian Thumboo Singapore 49 1.1k 0.7× 205 0.2× 1.5k 1.5× 1.3k 1.5× 1.2k 1.6× 391 8.9k
Erik Buskens Netherlands 62 1.7k 1.1× 357 0.4× 4.3k 4.4× 1.1k 1.2× 593 0.8× 283 13.2k
Corinne Alberti France 58 2.9k 1.9× 805 0.8× 1.6k 1.6× 446 0.5× 683 0.9× 283 12.4k

Countries citing papers authored by Michael J. Goodman

Since Specialization
Citations

This map shows the geographic impact of Michael J. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Goodman more than expected).

Fields of papers citing papers by Michael J. Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Goodman. The network helps show where Michael J. Goodman may publish in the future.

Co-authorship network of co-authors of Michael J. Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Goodman. A scholar is included among the top collaborators of Michael J. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Goodman. Michael J. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brott, David, et al.. (2018). Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?. Drug Design Development and Therapy. Volume 12. 2757–2773. 1 indexed citations
2.
Li, Yunfeng, Haijun Tian, Michael J. Goodman, et al.. (2014). Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia. ClinicoEconomics and Outcomes Research. 6. 349–349. 13 indexed citations
3.
Cohen, Elizabeth L., Jeremy R. Cooperstock, Andreas Floros, et al.. (2009). AES White Paper: Best Practices in Network Audio. Journal of the Audio Engineering Society. 57(9). 729–741. 11 indexed citations
4.
Mazor, Kathleen M., James E. Sabin, Denise M. Boudreau, et al.. (2007). Cluster Randomized Trials. Medical Care. 45(10). S29–S37. 27 indexed citations
5.
Mazzae, Elizabeth N., Michael J. Goodman, W. Riley Garrott, & Thomas A. Ranney. (2005). NHTSA’s research program on wireless phone driver interface effects. 2005. 12 indexed citations
6.
Neale, Vicki L., Thomas A. Dingus, Sheila G. Klauer, Jeremy Sudweeks, & Michael J. Goodman. (2005). An overview of the 100-car naturalistic study and findings. 2005. 250 indexed citations
7.
Garrott, W. Riley, Elizabeth N. Mazzae, & Michael J. Goodman. (2005). NHTSA's National Advanced Driving Simulator Research Program. 2005. 8 indexed citations
8.
Davis, Robert L., MARGARETTE S. KOLCZAK, Edwin Lewis, et al.. (2005). Active Surveillance of Vaccine Safety. Epidemiology. 16(3). 336–341. 103 indexed citations
9.
Saver, Barry G., Debra P. Ritzwoller, Michael V. Maciosek, et al.. (2004). Does payment drive procedures? Payment for specialty services and procedure rate variations in 3 HMOs.. PubMed. 10(3). 229–37. 5 indexed citations
10.
Fishman, Paul, Michael J. Goodman, Mark C. Hornbrook, et al.. (2003). Risk Adjustment Using Automated Ambulatory Pharmacy Data. Medical Care. 41(1). 84–99. 297 indexed citations
11.
Greene, Carol L. & Michael J. Goodman. (2003). Neonatal Abstinence Syndrome: Strategies for Care of the Drug-Exposed Infant. Neonatal Network The Journal of Neonatal Nursing. 22(4). 15–24. 16 indexed citations
12.
Fischer, Lucy Rose, et al.. (2002). Pharmaceutical care and health care utilization in an HMO.. PubMed. 5(2). 49–57. 14 indexed citations
13.
Ranney, Thomas A., W. Riley Garrott, & Michael J. Goodman. (2001). NHTSA DRIVER DISTRACTION RESEARCH: PAST, PRESENT, AND FUTURE. 2001. 211 indexed citations
14.
Chan, K. Arnold, Susan E. Andrade, Myde Boles, et al.. (2000). Inhibitors of Hydroxymethylglutaryl-Coenzyme A Reductase and Risk of Fracture Among Older Women. Obstetrical & Gynecological Survey. 55(11). 696–697. 16 indexed citations
15.
Hornbrook, Mark C. & Michael J. Goodman. (1996). Chronic disease, functional health status, and demographics: a multi-dimensional approach to risk adjustment.. PubMed. 31(3). 283–307. 128 indexed citations
16.
Tijerina, Louis & Michael J. Goodman. (1996). Use of workload assessment measures and methods to assess safety-relevant impacts of in-vehicle device use among heavy vehicle drivers. 1996. 1961–1972. 1 indexed citations
17.
Riley, S A, et al.. (1990). Why do patients with ulcerative colitis relapse?. Gut. 31(2). 179–183. 154 indexed citations
18.
Riley, S A, V Mani, Michael J. Goodman, et al.. (1988). Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.. Gut. 29(5). 669–674. 161 indexed citations
19.
Riley, S A, et al.. (1987). Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.. Gut. 28(8). 1008–1012. 82 indexed citations
20.
Goodman, Michael J. & S. C. Truelove. (1976). Intensive intravenous regimen for membranous colitis.. BMJ. 2(6031). 354–354. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026